HSTM saw its Momentum Indicator move above the 0 level on September 29, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 99 similar instances where the indicator turned positive. In 63 of the 99 cases, the stock moved higher in the following days. The odds of a move higher are at 64%.
The Moving Average Convergence Divergence (MACD) for HSTM just turned positive on September 30, 2026. Looking at past instances where HSTM's MACD turned positive, the stock continued to rise in 32 of 54 cases over the following month. The odds of a continued upward trend are 59%.
Following a +1.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where HSTM advanced for three days, in 167 of 299 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Aroon Indicator entered an Uptrend today. In 123 of 201 cases where HSTM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 61%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 12 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 28 of 58 cases where HSTM's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 48%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSTM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 53%.
HSTM broke above its upper Bollinger Band on October 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 24 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 31 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. HSTM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 76 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSTM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock better than average.
The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.858) is normal, around the industry mean (3.883). HSTM has a moderately high P/E Ratio (46.264) as compared to the industry average of (12.839). Projected Growth (PEG Ratio) (2.857) is also within normal values, averaging (2.133). Dividend Yield (0.004) settles around the average of (0.012) among similar stocks. P/S Ratio (2.711) is also within normal values, averaging (6.065).
WAY moved above its 50-day moving average on September 14, 2026 date and that indicates a change from a downward trend to an upward trend. In 8 of 8 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on WAY as a result. In 35 of 42 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
The Moving Average Convergence Divergence (MACD) for WAY just turned positive on October 06, 2026. Looking at past instances where WAY's MACD turned positive, the stock continued to rise in 20 of 23 cases over the following month. The odds of a continued upward trend are 87%.
Following a +7.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where WAY advanced for three days, in 110 of 139 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 67 of 79 cases where WAY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.
The 10-day RSI Indicator for WAY moved out of overbought territory on October 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 15 similar instances where the indicator moved out of overbought territory. In 10 of the 15 cases, the stock moved lower in the following days. This puts the odds of a move lower at 67%.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where WAY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.
WAY broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating fairly steady price growth. WAY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.346) is normal, around the industry mean (3.883). P/E Ratio (39.423) is within average values for comparable stocks, (12.839). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.133). Dividend Yield (0.000) settles around the average of (0.012) among similar stocks. P/S Ratio (4.228) is also within normal values, averaging (6.065).
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 86 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WAY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 97, placing this stock worse than average.
HSTM | ||
|---|---|---|
OUTLOOK RATING 1..100 | 43 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | |
PROFIT vs RISK RATING 1..100 | 76 | |
SMR RATING 1..100 | 81 | |
PRICE GROWTH RATING 1..100 | 36 | |
P/E GROWTH RATING 1..100 | 24 | |
SEASONALITY SCORE 1..100 | 31 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| HSTM | WAY | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 54% | 1 day ago 67% |
| Stochastic ODDS (%) | 1 day ago 48% | 1 day ago 61% |
| Momentum ODDS (%) | 1 day ago 64% | 1 day ago 83% |
| MACD ODDS (%) | 1 day ago 59% | 1 day ago 87% |
| TrendWeek ODDS (%) | 1 day ago 53% | 1 day ago 82% |
| TrendMonth ODDS (%) | 1 day ago 65% | 1 day ago 84% |
| Advances ODDS (%) | 8 days ago 56% | 6 days ago 79% |
| Declines ODDS (%) | 28 days ago 53% | 8 days ago 78% |
| BollingerBands ODDS (%) | 1 day ago 56% | 1 day ago 73% |
| Aroon ODDS (%) | 1 day ago 61% | 1 day ago 85% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
HSTM’s FA Score shows that 1 FA rating(s) are green while WAY’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
HSTM’s TA Score shows that 4 TA indicator(s) are bullish while WAY’s TA Score has 5 bullish TA indicator(s).
HSTM (@Services to the Health Industry) experienced а -0.45% price change this week, while WAY (@Services to the Health Industry) price change was +5.03% for the same time period.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -1.58%. For the same industry, the average monthly price growth was -2.78%, and the average quarterly price growth was +16.87%.
HSTM is expected to report earnings on Oct 26, 2026.
WAY is expected to report earnings on Nov 02, 2026.
This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
A.I.dvisor indicates that over the last year, WAY has been loosely correlated with VEEV. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if WAY jumps, then VEEV could also see price increases.
| Ticker / NAME | Correlation To WAY | 1D Price Change % | ||
|---|---|---|---|---|
| WAY | 100% | +2.30% | ||
| VEEV - WAY | 50% Loosely correlated | +2.08% | ||
| PHR - WAY | 46% Loosely correlated | +3.11% | ||
| TDOC - WAY | 46% Loosely correlated | +1.06% | ||
| HQY - WAY | 43% Loosely correlated | +1.13% | ||
| HSTM - WAY | 39% Loosely correlated | +0.54% | ||
More | ||||